IPO Boutique

Tetraphase Pharmaceuticals IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Tetraphase Pharmaceuticals, and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Tetraphase PharmaceuticalsTTPH - $10.00-$12.00 $7.00 $7.2010.7 million3/20/2013
Barclays, BMO Capital Markets
Co-Manager(s):
Stifel, JMP Securities, Needham & Company
Health Care
Filing(s):

Filed 2013-02-11



Tetraphase Pharmaceuticals Quote & Chart - Click for current quote - TTPH

About Tetraphase Pharmaceuticals (adapted from Tetraphase Pharmaceuticals prospectus):
They are a clinical stage biopharmaceutical company using our proprietary chemistry technology to create novel antibiotics for serious and life-threatening multi-drug resistant infections.

This description is adapted from Tetraphase TTPH prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as Tetraphase TTPH "TTPH" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved